对于与慢性鼻炎相关的金黄色葡萄球菌 (Staphylococcus aureus):一个体外研究中的simvastatin的抗菌活性
S P Goldie1,2, L P Lau1, H A S Jones2
1School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Rhinology
|July 14, 2025
概括
辛瓦斯在治疗慢性鼻炎 (CRS) 方面表现有前途,通过有效地减少细胞内外的金黄色葡萄球菌. 这种常见的药物可以提供一种新的方法,在没有传统抗生素的情况下治疗困难的CRS病例.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 黄金葡萄球菌细胞内感染有助于治疗耐药性慢性鼻炎 (CRS).
- 传统的抗生素难以穿透宿主细胞,限制了对细胞内细菌的有效性.
- 抗微生物耐药性是管理CRS的日益关注的问题.
研究的目的:
- 调查simvastatin对CRS相关的黄金葡萄球菌的抗菌潜力.
- 为了评估simvastatin在细胞外和细胞内环境中的有效性.
- 探索simvastatin作为一种潜在的替代或辅助治疗耐火性CRS.
主要方法:
- 稀释试验确定了simvastatin的最小抑制度 (MIC).
- 感染的巨细胞 (LAD2) 用simvastatin治疗,通过CFU计数和共聚焦显微镜评估细胞内活性.
- 乳酸脱酶 (LDH) 的测定测量了simvastatin对宿主细胞的细胞毒性.
主要成果:
- 辛巴斯塔丁的细胞外MIC为40 mmol/l,对黄金色杆菌的抗作用.
- 细胞内S. aureus负担以剂量依赖的方式减少了46倍.
- 西姆瓦斯塔丁 (30μmol/l) 显著降低了感染细胞的百分比,从32.8%降至15.3%;在100 mmol/l时观察到毒性.
结论:
- 西姆瓦斯塔丁在体外表现出显著的抗微生物活性,对抗与CRS相关的黄金色杆菌.
- 重新使用simvastatin作为局部药物可能为耐火性CRS提供一种节约抗生素的方法.
- 这一策略可能会改善外科手术结果并减轻抗菌素耐药性.
更多相关视频
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
7.1K
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
2.9K
相关概念视频
01:29Microbiota of the Respiratory Tract
197
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
197
01:25Mechanism of Antibiotic Resistance in MRSA
251
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
251
01:25Clinical Significance of Antibiotic Resistance
115
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115